Novo CEO pressed by Senate to cut prices of being overweight, diabetic issues medications CEO Lars Fruergaard Jørgensen advised lawmakers the organization would think about new talks with insurers with regards to the listing charges of Wegovy and copyright should they pledge to help keep the medicines on their own https://griffinilikl.mdkblog.com/36387540/everything-about-healthcare-news